TrialEye (London, England)2024

Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.

Andreas Stahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.